1.Bone morphogenetic protein-2-induced alpha 2 (I) collagen expression in odontoblastic MDPC-23 cells mediated by Smad proteins.
Wen-xi HE ; Zhong-ying NIU ; Shou-liang ZHAO ; Jie GAO ; Ping LI
Chinese Journal of Stomatology 2004;39(5):386-389
OBJECTIVETo characterize the role of Smads proteins in alpha 2 (I) collagen (COL1A2) gene expression induced by bone morphogenetic protein-2 (BMP-2) in odontoblast cell line MDPC-23.
METHODSEndogenous Smad protein expression was determined by immunocytochemistry. Smads function and their role in COL1A2 gene expression were investigated in cotransfection experiments using promoter-luciferase reporter gene construct.
RESULTSMDPC-23 cells expressed Smad1, Smad5 and Smad6. BMP-2 promoted the activation of COL1A2 promoter reporter construct. Transient overexpression of Smad1 or Smad5 was enhanced, while overexpression of Smad6 inhibited BMP-2-induced COL1A2 promoter activity. BMP-2 inducibility could be blocked by overexpression of Smad1 or Smad5 dominant negative mutant.
CONCLUSIONSSmad signaling is functioning and appears to be involved in BMP-2-induced COL1A2 collagen transcription in MDPC-23. Smad signaling may play an important role in odontoblast differentiation and dentin extracellular matrix formation mediated by BMP-2.
Animals ; Bone Morphogenetic Protein 2 ; Bone Morphogenetic Proteins ; genetics ; Cell Line ; Collagen ; genetics ; Collagen Type I ; Mice ; Odontoblasts ; cytology ; metabolism ; Smad Proteins ; physiology ; Transforming Growth Factor beta ; genetics
2.Differential expression of Bmp2, Bmp4 and Bmp3 in embryonic development of mouse anterior and posterior palate.
Chinese Medical Journal 2005;118(20):1710-1716
BACKGROUNDThe palate is differently regulated and developed along the anterior-posterior axis. The Bmp signal pathway plays a crucial role in palatogenesis. Conditioned-inactivation of Bmp type I receptor Alk2 or Alk3 in the neural crest or craniofacial region leads to palatal cleft in mice. However, how different Bmp members are involved in palatogenesis remains to be elucidated. In the present study, mRNA expression patterns of Bmp2, Bmp3 and Bmp4 in the developing anterior and posterior palates were examined and compared, focusing on the fusion stage.
METHODSTo detect the expression of Bmp mRNA, antisense riboprobes were synthesized by in vitro transcription. Radioactive in situ hybridization was performed on sagital and coronal sections of mice head from E13 to E18.
RESULTSThe expression of these Bmps were developmentally regulated in the anterior and posterior palates prior to, during and after palatal fusion. During palatal fusion, Bmp4 expression shifted from the anterior to the posterior palate, Bmp2 was highly expressed in both the anterior and posterior palates in this process, whereas Bmp3 was only localized in the posterior palate. They showed generally non-overlapping pattern in their expression domains. Thereafter, their expression was detected in both the anterior and posterior palates regulating osteogenesis and myogenesis respectively.
CONCLUSIONSBmp signalling is involved in palatogenesis in multiple stages and has multiple roles in regulating anterior and posterior palatal development. Disturbances of Bmp signalling during palatogenesis might be a possible mechanism of cleft palate.
Animals ; Bone Morphogenetic Protein 2 ; Bone Morphogenetic Protein 3 ; Bone Morphogenetic Protein 4 ; Bone Morphogenetic Proteins ; genetics ; Female ; Gene Expression Regulation, Developmental ; Mice ; Palate ; embryology ; metabolism ; RNA, Messenger ; analysis ; Signal Transduction ; Transforming Growth Factor beta ; genetics
3.Construction of eucaryotic expression plasmid carrying the BMP7 gene and expression in mesenchymal stem cells.
Shu-xun HOU ; Da-ming SUN ; Gui-xin DU ; Yi-gang TONG ; Xiao-bing FU
Chinese Journal of Surgery 2003;41(6):445-448
OBJECTIVESTo construct an eucaryotic expression plasmid carrying the BMP7 gene and express in MSCs.
METHODSThe BMP7 gene was cloned into the eucaryotic expression vector pcDNA3.1. At the same time, mesenchymal stem cells (MSCs) were isolated and cultured in vitro. The plasmid carrying the BMP7 gene was transfected into MSCs.
RESULTSPCR and digesting demonstrated that the eucaryotic expression plasmid -pcDNA-BMP7 was obtained. RT-PCR and immunohistochemical methods showed that the BMP7 gene was expressed in MSCs.
CONCLUSIONConstruction of an eucaryotic expression plasmid carrying BMP7 gene and expression in MSCs provide a sound basis for gene therapy using the BMP7 gene and the ideal seeds for tissue engineering.
Bone Morphogenetic Protein 7 ; Bone Morphogenetic Proteins ; genetics ; Genetic Therapy ; Humans ; Mesenchymal Stromal Cells ; metabolism ; Plasmids ; Polymerase Chain Reaction ; Tissue Engineering ; Transforming Growth Factor beta
4.Transfection of articular chondrocytes with rhBMP7 gene and its expression.
Deyu DUAN ; Jingyuan DU ; Yong LIU ; Xiaodong GUO ; Hong WANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2002;22(1):42-43
In order to investigate the possibility of expression of exogenous gene in transduced articular chondrocytes, plasmid pcDNA3-rhBMP7 was delivered to cultured chondrocytes. Through immunohistochemical staining and RT-PCR assay, the expression of rhBMP7 gene was detected. And the bioactivity of transgene expression product was detected through MTT assay as well. It was confirmed that exogenous gene could be expressed efficiently in transduced chondrocytes and the transgene expression product had obvious bioactivity. The present study provided a theoretical basis for gene therapy on the problems of articular cartilage.
Animals
;
Bone Morphogenetic Protein 7
;
Bone Morphogenetic Proteins
;
biosynthesis
;
genetics
;
Cartilage, Articular
;
metabolism
;
Chondrocytes
;
metabolism
;
Gene Expression
;
Rabbits
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
Transfection
;
Transforming Growth Factor beta
;
biosynthesis
;
genetics
;
metabolism
5.Construction and bio-activity of the chimeric protein of BMP2-EGFP.
Yin-gang ZHANG ; Xiong GUO ; Chang-hong SHI ; Ai-min ZOU ; Peng XU
Journal of Central South University(Medical Sciences) 2005;30(1):16-20
OBJECTIVE:
To construct the recombined retroviral expression vector of BMP2/pLEGFP and investigate the bio-activity of the expressed chimeric protein.
METHODS:
The recombinant vector constructed by gene recombinant technology was analyzed by restriction enzyme digestion and PCR. BMP2/pLEGFP was transfected into COS-7 cells with liposome transfection reagents for transient expression. The expression of chimeric protein BMP2/EGFP was identified by fluorescent microscope and Western blotting. The bio-activity was examined by the cellular activity and animal heterotopic osteogenesis experiment.
RESULTS:
The recombinant plasmid proved successful by restriction enzyme digestion and PCR. The expression of the chimeric protein was shown by fluorescent microscope and Western blotting. The chimeric protein had the double bio-activities of BMP2 and EGFP identified by the cellular activity and animal heterotopic osteogenesis tests.
CONCLUSION
The recombinant vector of BMP2/pLEGFP is successfully constructed by the gene recombinant technology and its chimeric protein has double bioactivities of BMP2 and EGFP.
Animals
;
Bone Morphogenetic Protein 2
;
Bone Morphogenetic Proteins
;
biosynthesis
;
genetics
;
COS Cells
;
Chlorocebus aethiops
;
Eukaryotic Cells
;
metabolism
;
Green Fluorescent Proteins
;
biosynthesis
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
Transfection
;
Transforming Growth Factor beta
;
biosynthesis
;
genetics
6.Expression of rhBMP-7 gene in transduced bone marrow derived stromal cells.
Deyu DUAN ; Jingyuan DU ; Hong WANG ; Yong LIU ; Xiaodong GUO
Chinese Medical Sciences Journal 2002;17(3):157-159
OBJECTIVETo explore the possibility of expression of exogenous gene in transduced bone marrow derived stromal cells (BMSCs).
METHODSThe marker gene, pbLacZ, was transferred into cultured BMSCs and the expression of transduced gene by X-gal staining was examined. Then plasmid pcDNA3-rhBMP7 was delivered to cultured BMSCs. Through immunohistochemical staining and RT-PCR assay, the expression of rhBMP7 gene was detected.
RESULTSThe exogenous gene could be expressed efficiently in transduced BMSCs.
CONCLUSIONThe present study provided a theoretical basis to gene therapy on the problems of bone and cartilage tissue.
Animals ; Bone Marrow Cells ; cytology ; metabolism ; Bone Morphogenetic Protein 7 ; Bone Morphogenetic Proteins ; biosynthesis ; genetics ; Cells, Cultured ; Genetic Vectors ; genetics ; Rabbits ; Recombinant Proteins ; biosynthesis ; Stromal Cells ; cytology ; metabolism ; Tibia ; cytology ; Transfection ; Transforming Growth Factor beta
7.Effect of human bone morphogenetic protein 2, 3, 6, and 12 on osteosarcoma cell line UMR106.
Xingxing LI ; Huanling HE ; Limei WU ; Wen MA ; Yinghua CHEN ; Jia WEI ; Jingkun MIAO ; Lan ZHOU
Journal of Central South University(Medical Sciences) 2010;35(5):464-469
OBJECTIVE:
To investigate the effect of human bone morphogenetic protein (hBMPs) 2/3/6 and 12 on osteosarcoma cell UMR106.
METHODS:
Adenovirus-BMP2/3/6 and 12 (AdBMP2/3/6 and12) were used to treat the cell line. Their proliferation, apoptosis, and transmigration were detected by Trypan blue exclusion test, TdT-mediated biotinylated-dUTP nick end labeling (TUNEL), acridine orange-ethidium bromide (AO/EB) double fluorescent dye staining, and transwell-room test, respectively. The alkaline phosphatase (ALP) activity was detected to reflect the differentiation of tumors.
RESULTS:
Compared with the control groups, the cell survival rate of the experimental groups treated with AdBMP2/3/6 and 12 showed a significant time-dependent decrease (P<0.01). The apoptosis indexes were increased significantly (P<0.01) and the results from TUNEL and AO/EB method were consistent. The cell numbers of transmembrane significantly decreased at 24,48, and 72 h (P<0.01). AdBMP2/3/6 and 12 treatment enhanced the activity of ALP activity from day 3 and this effect might still be observed up to day 9 of the treatment (P<0.01).
CONCLUSION
hBMPs2/3/6 and 12 can inhibit the proliferation and transmigration, and induce their apoptosis and differentiation in osteosarcoma cell line UMR106.
Adenoviridae
;
genetics
;
metabolism
;
Apoptosis
;
drug effects
;
Bone Morphogenetic Protein 2
;
pharmacology
;
Bone Morphogenetic Protein 3
;
pharmacology
;
Bone Morphogenetic Protein 6
;
pharmacology
;
Bone Morphogenetic Proteins
;
pharmacology
;
Bone Neoplasms
;
pathology
;
Cell Line, Tumor
;
Cell Transformation, Neoplastic
;
drug effects
;
Growth Differentiation Factors
;
pharmacology
;
Humans
;
Osteosarcoma
;
pathology
;
Recombinant Proteins
;
pharmacology
8.Effects of transient transfection of human BMP-4 gene on rabbit bone marrow stromal cells.
Xin-quan JIANG ; Zhi-yuan ZHANG ; Qing CHANG ; Jian-guo CHEN ; Xiao-jian ZHOU ; Wan-tao CHEN
Acta Academiae Medicinae Sinicae 2003;25(1):13-16
OBJECTIVEBone marrow stromal cells (MSCs) were transfected with human bone morphogenetic protein-4 (hBMP-4) gene in vitro to provide BMP gene modified cells for tissue-engineered bone.
METHODSMSCs were cultured and transfected with pEGFP-hBMP4, pEGFP plasmids respectively or left uninfected as control. Transcription of BMP-4 gene as well as gene transfection efficiency was tested. Morphological and growth feature of the transfected cells were valued. Alkaline phosphatase (ALP), von Kossa, and Osteocalcin (OC) were tested to determine the phenotypes of osteoblast.
RESULTSThe gene transfection efficiency was 20%-30%, based on GFP expression. RT-PCR showed that MSCs had low transcription of BMP-4 that was enhanced by the gene transfer. Morphological feature of MSCs transfected with pEGFP-hBMP-4 changed but growth curves did not show much difference among the groups. In pEGFP-hBMP-4 group, ALP positive stain area and the number of calcium nodules were increased, as well as the expression of OC.
CONCLUSIONSA high transfer efficiency of MSCs was achieved under optimized conditions. The gene transfer technique strengthened the transcription of BMP-4 and promoted differentiation from MSCs to osteoblasts. hBMP-4 transferred MSCs may serve as an ideal cell source for tissue-engineered bone.
Animals ; Bone Marrow Cells ; cytology ; Bone Morphogenetic Protein 4 ; Bone Morphogenetic Proteins ; biosynthesis ; genetics ; Cell Differentiation ; Cells, Cultured ; Gene Transfer Techniques ; Osteoblasts ; cytology ; metabolism ; Osteocalcin ; biosynthesis ; genetics ; Osteogenesis ; Rabbits ; Stromal Cells ; cytology ; Tissue Engineering ; Transfection
9.Effect of Homeobox A13 transfection on epithelial-mesenchymal transition and bone morphogenetic protein-7 expression in kidney tubular epithelial cells.
Li PENG ; Qing-Nan HE ; Xiao-Yan LI ; Lan-Jun SHUAI ; Hai-Xia CHEN ; Yong-Zhen LI ; Zhu-Wen YI
Chinese Journal of Contemporary Pediatrics 2015;17(12):1342-1347
OBJECTIVETo examine the transfection of Homeobox A13 (HOXA13) on epithelial-mesenchymal transition (EMT) and the expression of bone morphogenetic protein-7 (BMP-7) induced by albumin-overload in human kidney tubular epithelial cells (HKCs).
METHODSThe cultured HKCs were treated with 20 mg/mL human serum albumin (HSA) for 48 hours. Protein expression of cytokeratin (CK), vimentin and HOXA13 in the HKCs was assessed by Western blot. Protein expression of CK, vimentin, and BMP-7 was also detected in HKCs transfected with lipofectamine contained HOXA13 DNA.
RESULTSHSA induced EMT in HKCs, presented by decreased CK expression (P<0.01) and increased vimentin expression (P<0.01). The up-regulated expression of HOXA13 transfected by lipofectamine inhibited the level of EMT induced by HSA in HKCs (P<0.05). The decreased rate of BMP-7 protein expression induced by HSA was inhibited by over-expressed HOXA13 in HKCs (P<0.05).
CONCLUSIONSTransfection of HOXA13 in HKCs could inhibit the degree of EMT induced by albumin-overload, possibly by increasing BMP-7 expression.
Bone Morphogenetic Protein 7 ; genetics ; Cells, Cultured ; Epithelial Cells ; metabolism ; Epithelial-Mesenchymal Transition ; Homeodomain Proteins ; physiology ; Humans ; Keratins ; genetics ; Kidney Tubules ; metabolism ; Transfection ; Vimentin ; genetics
10.The ectopic study of tissue-engineered bone with hBMP-4 gene modified bone marrow stromal cells in rabbits.
Xin-quan JIANG ; Jian-guo CHEN ; Sébastien GITTENS ; Chuan-jun CHEN ; Xiu-li ZHANG ; Zhi-yuan ZHANG
Chinese Medical Journal 2005;118(4):281-288
BACKGROUNDTissue-engineering techniques combined with gene therapy have been recently reported to improve osteogenesis. In this study, tissue-engineered bone constructed by human Bone Morphogenetic Protein 4 (hBMP-4) gene-modified bone marrow stromal cells (bMSCs) was explored in an ectopic bone formation model in rabbits.
METHODSA pEGFP-hBMP-4 mammalian plasmid (EGFP: Enhanced Green Fluorescent Protein) was constructed by subcloning techniques. bMSCs obtained from rabbits were cultured and transfected with either pEGFP-hBMP-4, pEGFP or left uninfected in vitro. Transfer efficiency was detected through the expression of EGFP. Transcription of the target gene was detected by RT-PCR. Alkaline phosphatase (ALP) and Von Kossa tests were also conducted to explore the phenotypes of osteoblasts. The autologous bMSCs of the 3 groups were then combined with Natural Non-organic Bone (NNB), a porous hydroxyapatite implant with a dimension of 6 mm x 6 mm x 3 mm, at a concentration of 5 x 10(7) cells/ml. They were subsequently implanted into 6 rabbits subcutaneously using NNB alone as a blank control (6 implants per group). Four weeks after surgery, the implants were evaluated with histological staining and computerized analysis of new bone formation.
RESULTSpEGFP-hBMP-4 expression plasmid was constructed. Under optimal conditions, gene transfer efficiency reached more than 30%. Target gene transfer could strengthen the transcription of BMP-4, and increase the expression of ALP as well as the number of calcium nodules. In the ectopic animal model, NNB alone could not induce new bone formation. The new bone area formed in the bMSCs group was (17.2 +/- 7.1)%, and pEGFP group was (14.7 +/- 6.1)%, while pEGFP-hBMP-4 group was (29.5 +/- 8.2)%, which was the highest among the groups (F = 7.295, P < 0.01).
CONCLUSIONSThe mammalian hBMP-4 expression plasmid was successfully constructed and a comparatively high transfer efficiency was achieved. The gene transfer technique enhanced the expression of BMP-4 and promoted differentiation from bMSCs to osteoblasts. These in vivo results suggested that transfection of bMSCs with hBMP-4 might be a suitable method to enhance their inherent osteogenic capacity for bone tissue engineering applications.
Animals ; Bone Marrow Cells ; cytology ; metabolism ; Bone Morphogenetic Protein 4 ; Bone Morphogenetic Proteins ; genetics ; Cell Differentiation ; Gene Transfer Techniques ; Genetic Therapy ; Humans ; Osteogenesis ; Plasmids ; Rabbits ; Stromal Cells ; cytology ; metabolism ; Tissue Engineering